Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma

Erstveröffentlichung
2019
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Halatsch, Marc-Eric
Kast, Richard Eric
Dwucet, Annika
Hlavac, Michal
Heiland, Tim
et al.
Institutions
UKU. Klinik für Neurologie
UKU. Klinik für Neurochirurgie
UKU. Klinik für Kinder- und Jugendmedizin
Published in
British journal of clinical pharmacology ; 176 (2019), 18. - S. 3681-3694. - ISSN 0306-5251. - eISSN 1365-2125
Link to publication
https://dx.doi.org/10.1111/bph.14773
Funding information
National Institute of Neurological Disorders and Stroke [K08 NS083732, R01 NS095848, R01 NS102366]
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record